7-Methylguanine 17653 PTK inhibitors which preferentially inhibit

PTK inhibitors which preferentially inhibit the epidermal growth factor receptor (EGFR) kinase and block EGFR-dependent cell proliferation

is an antimetabolite drug used in treatment of colorectal cancer since 1998

H2O : 50 mg/mL (125

InChiKey: ZRKTWBXVGMHWHM-YCBFMBTMSA-N

In BSA-challenged mice

7-Methylguanine 17653 PTK inhibitors which preferentially inhibit7 Methylguanine is a metabolite of DNA methylation. It can be generated by methylating agents, and used as a probe of proteinDNA interactions and a key component of DNA sequencing method. Product information CAS Number: 578 76 7 Molecular Weight: 165. 15 Formula: C6H7N5O Chemical Name: 2 amino 7 methyl 6,7 dihydro 1H purin 6 one Smiles: CN1C=NC2N=C(N)NC(=O)C1=2 InChiKey: FZWGECJQACGGTI UHFFFAOYSA N InChi: InChI=1S C6H7N5O c1 11 2 8 4 3(11)5(12)10